Acceso abierto

Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report

Tobian Muir

Tobian Muir

Department of Reconstructive Plastic Surgery, James Cook University HospitalMiddlesbrough, United Kingdom
Buscar este autor en
Sciendo|Google Scholar
Muir, Tobian
, 
Giulia Bertino

Giulia Bertino

Department of Otolaryngology Head Neck Surgery, University of Pavia, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo FoundationPavia, Italy
Buscar este autor en
Sciendo|Google Scholar
Bertino, Giulia
, 
Ales Groselj

Ales Groselj

  • Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre LjubljanaLjubljana, Slovenia
  • Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Groselj, Ales
, 
Lakshmi Ratnam

Lakshmi Ratnam

Department of Interventional Radiology, St George's University Hospitals NHS Foundation TrustLondon, United Kingdom
Buscar este autor en
Sciendo|Google Scholar
Ratnam, Lakshmi
, 
Erika Kis

Erika Kis

Department of Dermatology and Allergology, University of SzegedSzeged, Hungary
Buscar este autor en
Sciendo|Google Scholar
Kis, Erika
, 
Joy Odili

Joy Odili

Department of Plastic Surgery, St. Georges University Hospitals NHS TrustLondon, United Kingdom
Buscar este autor en
Sciendo|Google Scholar
Odili, Joy
, 
Ian McCafferty

Ian McCafferty

Birmingham Women's and Children's Hospital NHS Foundation TrustBirmingham, United Kingdom
Buscar este autor en
Sciendo|Google Scholar
McCafferty, Ian
, 
Walter A Wohlgemuth

Walter A Wohlgemuth

Universitätsklinik und Poliklinik für Radiologie, Universitätsmedizin HalleHalle, Germany
Buscar este autor en
Sciendo|Google Scholar
Wohlgemuth, Walter A
, 
Maja Cemazar

Maja Cemazar

  • Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
  • Faculty of Health Sciences, University of PrimorskaSlovenia
Buscar este autor en
Sciendo|Google Scholar
Cemazar, Maja
, 
Aljosa Krt

Aljosa Krt

Department of Otorhinolaryngology, Izola General HospitalIzola, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Krt, Aljosa
, 
Masa Bosnjak

Masa Bosnjak

Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Bosnjak, Masa
, 
Alessandro Zanasi

Alessandro Zanasi

IGEA S.p.A., Clinical Biophysics Lab. CarpiModena, Italy
Buscar este autor en
Sciendo|Google Scholar
Zanasi, Alessandro
, 
Michela Battista

Michela Battista

IGEA S.p.A., Clinical Biophysics Lab. CarpiModena, Italy
Buscar este autor en
Sciendo|Google Scholar
Battista, Michela
, 
Francesca de Terlizzi

Francesca de Terlizzi

IGEA S.p.A., Clinical Biophysics Lab. CarpiModena, Italy
Buscar este autor en
Sciendo|Google Scholar
de Terlizzi, Francesca
, 
Luca G Campana

Luca G Campana

Department of Surgery, Manchester University NHS Foundation TrustManchester, United Kingdom
Buscar este autor en
Sciendo|Google Scholar
Campana, Luca G
 y 
Gregor Sersa

Gregor Sersa

  • Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
  • Faculty of Health Sciences, University of LjubljanaLjubljana, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Sersa, Gregor
  
21 jun 2023
Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Review
Publicado en línea: 21 jun 2023
Páginas: 141 - 149
Recibido: 26 may 2023
Aceptado: 03 jun 2023
DOI: https://doi.org/10.2478/raon-2023-0029
Palabras clave
© 2023 Tobian Muir et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

FIGURE 1.

Treatment of vascularized melanoma metastasis by electrochemotherapy. (A) Highly vascularized tumor before treatment. (B) Bleeding due to electrode insertion after application of electric pulses to the tumor. (C) Bleeding stopped immediately after electric pulse application.
Treatment of vascularized melanoma metastasis by electrochemotherapy. (A) Highly vascularized tumor before treatment. (B) Bleeding due to electrode insertion after application of electric pulses to the tumor. (C) Bleeding stopped immediately after electric pulse application.

FIGURE 2.

Patient treated by BEST. Axial T2-weighted, fat-saturated MRI with hyperintense (arrow) gluteal venous malformation before treatment (A). Axial T2-weighted, fat-saturated MRI of the same region 4 months after treatment. The main part of the venous malformation is occluded (B). Photography before (C) and after the treatment (D).
Patient treated by BEST. Axial T2-weighted, fat-saturated MRI with hyperintense (arrow) gluteal venous malformation before treatment (A). Axial T2-weighted, fat-saturated MRI of the same region 4 months after treatment. The main part of the venous malformation is occluded (B). Photography before (C) and after the treatment (D).

Clinical studies and case reports using bleomycin electrosclerotherapy40,41,42,43,44,45

Reference Type of malformation N of pts Bleomycin dose and concentration Electrodes used N of pulse applications Response Comment
McMorrow et al., Br J Oral and Maxillofacial Surg 201744 Venous malformation 1 Reduced dose: 1/3 of the standard dose Not reported Not reported Considerable improvement after 6 unsuccessful sessions with bleomycin Case report with poor respiratory function
Horbach et al., Dermatologic Surgery 202045 Hypertrophic capillary malformations 5 pts. (out of 20 planned) 0.25 mg or units/cm3 Plate & needle Not reported 7–8 weeksDEROI (changes in colorimetry)Flux in ROI (in Perfusion Units) Randomized controlled pilot trial
Dalmady et al., Pediatrics 202043 Lymphatic malformation 1 0.5 mg/kg (5.4 mg) Needle 1st session: 68 applications2nd session: 74 applications 63% growth-corrected volume decrease.No recurrence at 18 months Follow up Case report
Wohlgemuth et al., Journal of Vascular Surgery 202140 Venous malformations 17 pts. (20 lesions) Calculated based on the size of the lesion.C = 0.25 mg/mL Intralesional injection (25% concentration of standard bleomycin sclerotherapy) Needle & finger Not reported 3-month post-therapy Changes in volume MRI: Volume reduction,%:
> 90% 9 lesions Retrospective observational case study
> 70% in < 90% 6 lesions
> 50% in < 70% 2 lesions
< 35% 2 lesions
No response 1 lesion
Kostusiak et al., Dermatologic Surgery 202242 Various vascular malformations 30 pts.VM: 17AVM: 3CVMLM: 2Mixed: 2 Calculated based on the size of the lesion.Bleomycin mixed with 1 mL plain 1% lidocaineDose not reported Needle & finger Not reported 17 Complete Response7: significant improvement1: moderate improvement1: minor response1: no response3: active follow up Prospective observational case studyElectrosclerotherapy offered to non-responding patients to standard bleomycin
Krt et al., Front Oncol 202241 Arteriovenous malformation 1 750 IU BLM intralesional Plate 15 CR 18 months after BEST Case report

International Society for the Study of Vascular Anomalies (ISSVA) classification for vascular anomalies 2018

VASCULAR TUMORS VASCULAR MALFORMATIONS
Benign Locally aggressive Malignant Simple Combined
Infantile hemangioma Kaposiform hemangioendothelioma Capillary malformation (CM) CVM, CLM
Congenital hemangioma Retiform hemangioendothelioma Lymphatic malformation (LM) LVM. CLVM
Tufted hemangioma PILA. Dabska tumor Epithelioid hemangioendothelioma Venous malformation (VM) CAVM
Spindle-cell hemangioma Composite hemangioendothelioma Angiosarcoma Arteriovenous malformation (AVM)
Epithelioid hemangioma Kaposi sarcoma Arteriovenous fistula CLAVM
Pyogenic granuloma
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina Interna, Hematología, oncología, Radiología
RSS Feed de revista